Table II.
Baseline Comorbidities in Patients With Refractory and Controlled Resistant Hypertension
| Comorbidity | Refractory Hypertension (n=29) | Controlled RHTN (n=275) | P Value |
|---|---|---|---|
| Obstructive sleep apnea | 9 (31.0) | 151 (54.9) | .01 |
| Chronic kidney disease | 7 (24.1) | 38 (13.8) | .14 |
| Diabetes | 11 (37.9) | 77 (28.0) | .26 |
| Coronary artery disease | 4 (13.8) | 37 (13.5) | .96 |
| Dyslipidemia | 15 (51.7) | 133 (48.4) | .73 |
| Congestive heart failure | 7 (24.1) | 11 (4.0) | <.0001 |
| Stroke | 8 (27.6) | 22 (8.0) | .004 |
Abbreviation: RHTN, resistant hypertension. Values are expressed as number (percentage). P values denote refractory hypertension group compared with the controlled RHTN group.